CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale Chief Financial Officer sold 1,697 shares at $6.03 ($10,233)
- 4 Open-market sale President, R&D sold 3,451 shares at $6.03 ($20,810)
- 4 Open-market sale Chief Legal Officer sold 1,632 shares at $6.03 ($9,841)
- 4 Grant or award President and CEO acquired 1,662 shares (grant or award)
- 4 Open-market sale President, R&D sold 648 shares at $8.38 ($5,430)
- 4 Open-market sale See remarks sold 244 shares at $8.38 ($2,045)
- 4 Open-market sale Chief Financial Officer sold 294 shares at $8.38 ($2,464)
- 4 Open-market sale Chief Legal Officer sold 294 shares at $8.38 ($2,464)
- 4 Open-market sale See remarks sold 1,352 shares at $11.80 ($15,954)
- 4 Open-market sale Chief Financial Officer sold 1,693 shares at $11.80 ($19,977)
- 4 Open-market sale President, R&D sold 2,683 shares at $11.80 ($31,659)
- 4 Open-market sale Chief Legal Officer sold 1,628 shares at $11.80 ($19,210)
- 4 Open-market sale See remarks sold 244 shares at $12.12 ($2,957)
- 4 Open-market sale Chief Financial Officer sold 294 shares at $12.12 ($3,563)
- 4 Open-market sale President, R&D sold 647 shares at $12.12 ($7,842)
- 4 Open-market sale Chief Legal Officer sold 294 shares at $12.12 ($3,563)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 16 · 320 filings